2 Biotech Firms Tap Thawing IPO Market To Raise $239M Total
Shares of drug developers Fractyl Health Inc. and Alto Neuroscience Inc. began trading with mixed results on Friday after the life sciences startups raised nearly $239 million combined in initial public...To view the full article, register now.
Already a subscriber? Click here to view full article